BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 23726612)

  • 1. Antithymocyte globulin induction and rapid steroid taper leads to excellent results in kidney transplantation with donation after cardiac death donors: importance of rejection and delayed graft function.
    Mai ML; Mai WK; Taner CB; Prendergast MB; Wadei HM; Gonwa TA
    Transplant Proc; 2013 May; 45(4):1528-30. PubMed ID: 23726612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of delayed graft function and acute rejection on outcomes after kidney transplantation from donors after cardiac death.
    Nagaraja P; Roberts GW; Stephens M; Horvath S; Fialova J; Chavez R; Asderakis A; Kaposztas Z
    Transplantation; 2012 Dec; 94(12):1218-23. PubMed ID: 23154212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes.
    Singh RP; Farney AC; Rogers J; Zuckerman J; Reeves-Daniel A; Hartmann E; Iskandar S; Adams P; Stratta RJ
    Clin Transplant; 2011; 25(2):255-64. PubMed ID: 20331689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of kidney function between donation after cardiac death and donation after brain death kidney transplantation.
    Wadei HM; Heckman MG; Rawal B; Taner CB; Farahat W; Nur L; Mai ML; Prendergast M; Gonwa TA
    Transplantation; 2013 Aug; 96(3):274-81. PubMed ID: 23778649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: single-center and organ procurement and transplantation network analyses.
    Wadei HM; Bulatao IG; Gonwa TA; Mai ML; Prendergast M; Keaveny AP; Rosser BG; Taner CB
    Liver Transpl; 2014 Jun; 20(6):728-35. PubMed ID: 24648186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed graft function does not harm the future of donation-after-cardiac death in kidney transplantation.
    Le Dinh H; Weekers L; Bonvoisin C; Krzesinski JM; Monard J; de Roover A; Squifflet JP; Meurisse M; Detry O
    Transplant Proc; 2012 Nov; 44(9):2795-802. PubMed ID: 23146527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of kidneys from paediatric DCD donors: a comparison with DBD donors.
    de Vries EE; Hoogland PE; Wind J; Snoeijs MG; van Heurn EL
    Nephrol Dial Transplant; 2013 Jan; 28(1):220-6. PubMed ID: 23197676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney transplantation from donors after brain or cardiac death in China--a clinical analysis of 94 cases.
    Wang C; Liu L; Fu Q; Meng F; Li J; Deng S; Fei J; Yuan X; Han M; Chen L; Qiu J; Chen G; Wang H; Huo F; Li J; Lin M; He X
    Transplant Proc; 2013 May; 45(4):1323-6. PubMed ID: 23726563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of expanded criteria variables on outcomes of kidney transplantation from donors after cardiac death.
    Nagaraja P; Roberts GW; Stephens M; Horvath S; Kaposztas Z; Chavez R; Asderakis A
    Transplantation; 2015 Jan; 99(1):226-31. PubMed ID: 25099703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal.
    Saull HE; Enderby CY; Gonwa TA; Wadei HM
    Clin Transplant; 2015 Jul; 29(7):573-80. PubMed ID: 25711849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support.
    Farney AC; Singh RP; Hines MH; Rogers J; Hartmann EL; Reeves-Daniel A; Gautreaux MD; Iskandar SS; Adams PL; Stratta RJ
    J Am Coll Surg; 2008 May; 206(5):1028-37; discussion 1037. PubMed ID: 18471749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An mTOR-inhibitor-based protocol and calcineurin inhibitor (CNI)-free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI.
    Sánchez-Escuredo A; Diekmann F; Revuelta I; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Peri L; Ruiz Á; Campistol JM; Oppenheimer F
    Transpl Int; 2016 Mar; 29(3):362-8. PubMed ID: 26678359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor kidney disease and transplant outcome for kidneys donated after cardiac death.
    Wells AC; Rushworth L; Thiru S; Sharples L; Watson CJ; Bradley JA; Pettigrew GJ
    Br J Surg; 2009 Mar; 96(3):299-304. PubMed ID: 19224513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of kidney donor profile index on delayed graft function and transplant outcomes: A single-center analysis.
    Zens TJ; Danobeitia JS; Leverson G; Chlebeck PJ; Zitur LJ; Redfield RR; D'Alessandro AM; Odorico S; Kaufman DB; Fernandez LA
    Clin Transplant; 2018 Mar; 32(3):e13190. PubMed ID: 29314286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donation after cardiac death: the University of Wisconsin experience.
    D'Alessandro AM; Fernandez LA; Chin LT; Shames BD; Turgeon NA; Scott DL; Di Carlo A; Becker YT; Odorico JS; Knechtle SJ; Love RB; Pirsch JD; Becker BN; Musat AI; Kalayoglu M; Sollinger HW
    Ann Transplant; 2004; 9(1):68-71. PubMed ID: 15478896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death.
    Schadde E; D'Alessandro AM; Knechtle SJ; Odorico J; Becker Y; Pirsch J; Sollinger H; Fernandez LA
    Transpl Int; 2008 Jul; 21(7):625-36. PubMed ID: 18397178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More donors or more delayed graft function? A cost-effectiveness analysis of DCD kidney transplantation.
    Snyder RA; Moore DR; Moore DE
    Clin Transplant; 2013; 27(2):289-96. PubMed ID: 23350938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
    Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC
    Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of kidney transplantation from elderly donors after cardiac death.
    Thornton SR; Hamilton N; Evans D; Fleming T; Clarke E; Morgan J; Kadi N
    Transplant Proc; 2011 Dec; 43(10):3686-9. PubMed ID: 22172826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.